{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:27:23Z","timestamp":1754159243200,"version":"3.41.2"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Current evidence from randomized controlled trials (RCTs) supports the anti-osteoporotic properties of Chinese Herbal Medicine (CHM); however, its therapeutic advantages over conventional treatments remain inconclusive. This study aimed to compare the therapeutic effects of CHM with those of conventional therapy in patients with osteoporosis, using a meta-analysis approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic search of PubMed, Embase, Cochrane Library, CNKI, and Wanfang databases was conducted through March 2025 to identify eligible RCTs. The weighted mean difference (WMD) and 95% confidence intervals (CI) were used as effect estimates, with pooled analyses calculated using a random-effects model. Additional exploratory analyses included sensitivity and subgroup analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighteen RCTs involving a total of 1,816 patients with osteoporosis were included in the meta-analysis. CHM was associated with increased bone mineral density (BMD) at the lumbar spine (WMD: 0.09; 95% CI: 0.04 to 0.13; <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001), femoral neck (WMD: 0.09; 95% CI: 0.02 to 0.17; <jats:italic>p<\/jats:italic>\u202f=\u202f0.015), and Ward\u2019s triangle area (WMD: 0.08; 95% CI: 0.01 to 0.15; <jats:italic>p<\/jats:italic>\u202f=\u202f0.025). However, CHM showed no significant effect on BMD at the greater trochanter of the femur (WMD: 0.01; 95% CI: \u22120.03 to 0.05; <jats:italic>p<\/jats:italic>\u202f=\u202f0.698). Additionally, CHM was not associated with changes in alkaline phosphatase (WMD: 0.98; 95% CI: \u22126.88 to 8.83; <jats:italic>p<\/jats:italic>\u202f=\u202f0.808), serum calcium (WMD: 0.08; 95% CI: \u22120.09 to 0.25; <jats:italic>p<\/jats:italic>\u202f=\u202f0.372), or serum phosphorus (WMD: -0.05; 95% CI: \u22120.22 to 0.12; <jats:italic>p<\/jats:italic>\u202f=\u202f0.574).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Chinese Herbal Medicine was associated with significant improvements in BMD at the lumbar spine, femoral neck, and Ward\u2019s triangle area compared to conventional therapies, though the evidence is limited by moderate study quality and high heterogeneity. The findings suggest potential benefits of CHM in specific skeletal sites, but further rigorous trials are needed to confirm efficacy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>INPLASY platform (number: INPLASY202530115).<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1620264","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:25:54Z","timestamp":1753421154000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Chinese herbal medicine in patients with osteoporosis: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Jin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11657-024-01380-9","article-title":"Bone evaluation study-2: update on the epidemiology of osteoporosis in Germany","volume":"19","author":"Hadji","year":"2024","journal-title":"Arch Osteoporos"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11657-019-0670-6","article-title":"Estimation and projection about the standardized prevalence of osteoporosis in mainland China","volume":"15","author":"Cui","year":"2019","journal-title":"Arch Osteoporos"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis","volume":"4","author":"S\u00f6zen","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"ref4","first-page":"346","article-title":"Prevalence of osteoporosis in Chinese elderly people: a meta-analysis","volume":"25","author":"Zhu","year":"2022","journal-title":"Chin General Pract"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos Int"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/medicina57101119","article-title":"Fragility fractures: risk factors and management in the elderly","volume":"57","author":"Migliorini","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00198-003-1544-7","article-title":"Undertreatment with anti-osteoporotic drugs after hospitalization for fracture","volume":"15","author":"Panneman","year":"2004","journal-title":"Osteoporos Int"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1007\/s00198-014-2827-x","article-title":"Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA","volume":"25","author":"Wilk","year":"2014","journal-title":"Osteoporos Int"},{"key":"ref9","first-page":"1022","article-title":"Absolute risk for fracture and WHO guideline. Fracture risk assessments recommended by World Health Organization and Japanese guidelines for prevention and treatment of osteoporosis 2006","volume":"17","author":"Nakamura","year":"2007","journal-title":"Clin Calcium"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40265-024-02138-w","article-title":"Treatment of osteoporosis and osteoarthritis in the oldest old","volume":"85","author":"Fuggle","year":"2025","journal-title":"Drugs"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2106\/JBJS.K.01181","article-title":"Bisphosphonates and nonhealing femoral fractures: analysis of the FDA adverse event reporting system (FAERS) and international safety efforts: a systematic review from the research on adverse drug events and reports (RADAR) project","volume":"95","author":"Edwards","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jocd.2017.07.003","article-title":"Chinese herbal medicine for osteoporosis: a meta-analysis of randomized controlled trials","volume":"20","author":"Jin","year":"2017","journal-title":"J Clin Densitom"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref14","volume-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series no. 843","year":"1994"},{"key":"ref15","volume-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated march 2011)","author":"Higgins","year":"2011"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/0272989X05282643","article-title":"The interpretation of random-effects metaanalysis in decision models","volume":"25","author":"Ades","year":"2005","journal-title":"Med Decis Mak"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch9","article-title":"Analyzing data and undertaking meta-analyses","volume-title":"Cochrane handbook for systematic reviews of interventions 5.0.1","author":"Deeks","year":"2008"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref20","first-page":"15","article-title":"Assessing the influence of a single study in the meta-analysis","volume":"47","author":"Tobias","year":"1999","journal-title":"Stata Tech Bull"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"ref24","first-page":"526","article-title":"Clinical study of Bugu Shengsui capsule in treating primary osteoporosis with kidney-Yang deficiency syndrome","volume":"17","author":"Xie","year":"1997","journal-title":"Chin J Integr Tradit Western Med"},{"key":"ref25","first-page":"679","article-title":"Efficacy observation of bushen jiangu tang in the treatment of primary osteoporosis complicated with fracture","volume":"18","author":"Shi","year":"2001","journal-title":"J Guangxi Med Univ"},{"key":"ref26","first-page":"263","article-title":"Clinical observation of Jiawei bushen Zhuangjintang on the treatment of primary osteoporosis","volume":"15","author":"Lv","year":"2002","journal-title":"China J Orthop Trauma"},{"key":"ref27","first-page":"69","article-title":"Effects of bushenzhuanggu capsule on primary osteoporosis","volume":"25","author":"Wang","year":"2005","journal-title":"Harbin Med J"},{"key":"ref28","first-page":"26","article-title":"Clinical observation of Bushen (Tonifying the kidney) prescription in the treatment of 95 cases of primary osteoporosis of kidney deficiency type","volume":"22","author":"Ke","year":"2005","journal-title":"ITCM"},{"key":"ref29","first-page":"30","article-title":"Clinical observation on the treatment of osteoporosis in menopausal women by the method of tonifying the kidney and nourishing essence","volume":"17","author":"Pan","year":"2006","journal-title":"J Shanxi Univ Tradit Chin Med"},{"key":"ref30","first-page":"1037","article-title":"Multicenter randomized controlled trial of Zhuanggu granules in the treatment of primary osteoporosis","volume":"35","author":"Luo","year":"2008","journal-title":"Liaoning J Tradit Chin Med"},{"key":"ref31","first-page":"53","article-title":"Clincial observation on post-menopause osteoporosis treated with yiguyin","volume":"33","author":"Li","year":"2009","journal-title":"J Zhejiang College Tradit Chin Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3736\/jcim20121210","article-title":"Effects of Chinese herbal medicine Qianggu capsule on patients with rheumatoid arthritis-induced osteoporosis: a report of 82 cases","volume":"10","author":"Ouyang","year":"2012","journal-title":"J Chin Integr Med"},{"key":"ref33","first-page":"108","article-title":"Comparison of three therapy results in a 2-year research on osteoporosis","volume":"26","author":"Ma","year":"2012","journal-title":"Chin Prim Health Care"},{"key":"ref34","volume-title":"A randomized, double-blind, placebo controlled clinical study on Bushenhuoxue granul treatment for postmenopausal osteoporosis","author":"Li","year":"2013"},{"key":"ref35","first-page":"20","article-title":"Effect of Bushen Zhuanggu decoction in the treatment of postmenopausal osteoporosis randomized parallel controlled study","volume":"27","author":"Zhang","year":"2013","journal-title":"J Pract Tradit Chin Int Med"},{"key":"ref36","first-page":"103","article-title":"Clinical observation on treating 100 cases of OP by the Jianpi Bushen method","volume":"6","author":"Liang","year":"2014","journal-title":"CJCM"},{"key":"ref37","first-page":"696","article-title":"Clinical observation of Buzhongyiqi decoction on senile osteoporosis","volume":"36","author":"Ma","year":"2014","journal-title":"Hebei J Tradit Chin Med"},{"key":"ref38","volume-title":"Clinical observation of nourishing liver and kidney decoction to treat glococorticoid-induced osteoporosis","author":"Hu","year":"2020"},{"key":"ref39","first-page":"676","article-title":"Randomized controlled clinical study on the treatment of osteoporosis with consolidating origin and improving bone formula in the elderly","volume":"26","author":"Gong","year":"2020","journal-title":"Chin J Osteoporos"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"4846392","DOI":"10.1155\/2023\/4846392","article-title":"Study on the effect of Bushen Zhuanggu tablet combined with conventional regimen on bone mineral density improvement, functional recovery and fracture risk prevention in patients with postmenopausal osteoporosis","volume":"2023","author":"Chen","year":"2023","journal-title":"Comput Math Methods Med"},{"key":"ref41","first-page":"1155","article-title":"Effect of Yishen Gushu formula on bone metabolic markers and clinical efficacy in patients with osteoporosis of kidney deficiency and blood stasis type","volume":"28","author":"Zhang","year":"2024","journal-title":"Chin J Tissue Eng Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.bbrc.2018.11.201","article-title":"Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-\u03baB and MAPK signaling pathways","volume":"508","author":"Xu","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jsps.2021.10.009","article-title":"Icariin regulates miR-23a-3p-mediated osteogenic differentiation of BMSCs via BMP-2\/Smad5\/Runx2 and WNT\/\u03b2-catenin pathways in osteonecrosis of the femoral head","volume":"29","author":"Zhang","year":"2021","journal-title":"Saudi Pharm J"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"12970","DOI":"10.1038\/s41598-018-31118-w","article-title":"Germinated soy germ with increased soyasaponin ab improves BMP-2-induced bone formation and protects against in vivo bone loss in osteoporosis","volume":"8","author":"Choi","year":"2018","journal-title":"Sci Rep"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbrc.2015.09.014","article-title":"Notoginsenoside R1 stimulates osteogenic function in primary osteoblasts via estrogen receptor signaling","volume":"466","author":"Wang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"110721","DOI":"10.1016\/j.cbi.2023.110721","article-title":"Codonopsis pilosula polysaccharides promote osteogenic differentiation and inhibit lipogenic differentiation of rat bone marrow stem cells by activating \u03b2-catenin","volume":"385","author":"Liu","year":"2023","journal-title":"Chem Biol Interact"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4238\/gmr15049169","article-title":"Effect of Astragalus polysaccharides on ovariectomy-induced osteoporosis in mice","volume":"15","author":"Huo","year":"2016","journal-title":"Genet Mol Res"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"102643","DOI":"10.1016\/j.arr.2024.102643","article-title":"The role and mechanism of triptolide, a potential new DMARD, in the treatment of rheumatoid arthritis","volume":"104","author":"Wang","year":"2025","journal-title":"Ageing Res Rev"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.chmed.2021.01.003","article-title":"High water-soluble curcuminoids-rich extract regulates osteogenic differentiation of MC3T3-E1 cells: involvement of Wnt\/\u03b2-catenin and BMP signaling pathway","volume":"13","author":"Pengjam","year":"2021","journal-title":"Chin Herb Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1557717","DOI":"10.3389\/fphar.2025.1557717","article-title":"Kansui-liquorice enhances the \"water-expelling\" effect of Gansui Banxia decoction in rats with malignant ascites by targeting the NPs\/NPRs\/cGMP\/PKGII pathway and T cell immunity","volume":"16","author":"Huo","year":"2025","journal-title":"Front Pharmacol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00198-005-2000-7","article-title":"Determinants of bone mineral density in Chinese men","volume":"16","author":"Cheung","year":"2005","journal-title":"Osteoporos Int"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/jor.25116","article-title":"Sex differences in systemic bone and muscle loss following femur fracture in mice","volume":"40","author":"Osipov","year":"2022","journal-title":"J Orthop Res"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"112704","DOI":"10.1016\/j.exger.2025.112704","article-title":"Young bone marrow transplantation delays bone aging in old mice","volume":"202","author":"Abu-Nada","year":"2025","journal-title":"Exp Gerontol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"126600","DOI":"10.1016\/j.ijbiomac.2023.126600","article-title":"Dendrobium offificinale polysaccharides prevents glucocorticoids-induced osteoporosis by destabilizing KEAP1-NRF2 interaction","volume":"253","author":"Wang","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4142\/jvs.2003.4.2.151","article-title":"Studies on the effects of biomedicinal agents on serum concentration of Ca2+, P and ALP activity in osteoporosis-induced rats","volume":"4","author":"Kim","year":"2003","journal-title":"J Vet Sci"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"106226","DOI":"10.1016\/j.fitote.2024.106226","article-title":"Cardenolides; calotropin and gomphogenin from Calotropis procera (Aiton) mitigate bone turnover in ovariectomized osteoporotic rats: targeting RANKL\/OPG axis and estrogen receptor-alpha","volume":"179","author":"Mettwally","year":"2024","journal-title":"Fitoterapia"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1002\/fsn3.1824","article-title":"Lactobacillus fermentum ZS40 prevents secondary osteoporosis in Wistar rat","volume":"8","author":"Liu","year":"2020","journal-title":"Food Sci Nutr"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fphar.2019.00411","article-title":"Geniposide alleviates glucocorticoid-induced inhibition of osteogenic differentiation in MC3T3-E1 cells by ERK pathway","volume":"10","author":"Xie","year":"2019","journal-title":"Front Pharmacol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1620264\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:25:59Z","timestamp":1753421159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1620264\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":58,"alternative-id":["10.3389\/fmed.2025.1620264"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1620264","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"article-number":"1620264"}}